 WAYNE, Pa., Dec. 15, 2020 GLOBE NEWSWIRE -- Aclaris Therapeutics, Inc. NASDAQ: ACRS, a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the formation of a new Scientific Advisory Board consisting of Stanley Cohen, MD, Marco Colonna, MD, James Krueger, MD, PhD, and Michael Weinblatt, MD. 